首页 > 市场调查报告书 > 材料

包装/容器

市场调查报告书

商品编码

1465582

空胶囊市场规模- 按类型（明胶、素食胶囊）、来源（猪明胶、牛源明胶、骨粉、淀粉材料和普鲁兰多醣）、功能、胶囊尺寸、应用、最终用户和全球预测，2024 - 2032年

Empty Capsules Market Size - By Type (Gelatin, Vegetarian Capsules), Source (Porcine Gelatin, Bovine Derived Gelatin, Bone Meal, Starch Materials & Pullulan), Functionality, Capsule Size, Application, End-user & Global Forecast, 2024 - 2032

出版日期: 2024年02月29日 | 出版商:

Global Market Insights Inc. | 英文 224 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于胶囊製造技术的不断进步以及人们对明胶和非明胶胶囊的日益青睐，全球空胶囊市场规模在 2024 年至 2032 年间将呈现 7.7% 的复合年增长率。这些进步提高了胶囊的品质、稳定性以及与各种配方的兼容性。明胶胶囊在製药和营养保健品领域仍然很受欢迎，而 HPMC 和普鲁兰多醣等非明胶胶囊则迎合了素食主义者和纯素食主义者的偏好。这种技术创新和多样化胶囊偏好的双重趋势将推动空心胶囊行业向前发展。

例如，2023 年 2 月，Operio 集团旗下品牌、全球配料解决方案提供商 Vivion, Inc. 推出了一系列新的 HPMC、空明胶和支链淀粉胶囊。

空胶囊产业根据类型、来源、功能、胶囊尺寸、应用、最终用户和地区而分散。

由于全球膳食补充剂和功能性食品的需求不断增长，到 2032 年，营养保健品产业将建立显着的市场立足点。空胶囊为营养保健品提供了一种方便且可客製化的输送方式，吸引了寻求健康和保健解决方案的消费者。随着对天然成分和健康趋势的关注，营养保健品产业将推动对空胶囊的需求。

由于牛源明胶在药品、营养保健品和膳食补充剂中的广泛应用，从 2024 年到 2032 年，其空胶囊市场份额将显着上升。牛明胶胶囊具有出色的稳定性和与多种配方的相容性，使其成为製造商的首选。随着製药业对明胶胶囊的需求不断增长以及营养保健品的日益普及，牛源明胶领域将保持其在空心胶囊市场的主导地位。

在製药和营养保健品产业不断扩张的推动下，尤其是在中国和印度等国家，亚太空心胶囊市场将在 2024 年至 2032 年间实现显着的复合年增长率。医疗保健支出的增加和人口老化的加剧也增加了对空胶囊的需求。随着研发投资的增加，亚太地区将成为市场扩张的关键贡献者，在药物传输和膳食补充剂领域提供广泛的应用。

产业生态系统分析
产业影响力
- 成长动力
  - 空心胶囊的技术进步
  - 全球心血管疾病等慢性病盛行率不断上升
  - 增加膳食补充剂和维生素的摄取量
- 产业陷阱与挑战
  - 原物料价格波动
  - 文化习俗和饮食限制
成长潜力分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
竞争定位矩阵
战略仪錶板

第 5 章：市场估计与预测：按类型，2018 - 2032

主要趋势
明胶胶囊
- 硬胶囊
- 软胶囊
素食胶囊

第 6 章：市场估计与预测：按来源划分，2018 年 - 2032 年

主要趋势
猪明胶
牛源明胶
骨粉
羟丙基甲基纤维素（HPMC）
淀粉原料及普鲁兰多醣

第 7 章：市场估计与预测：按功能划分，2018 年 - 2032 年

主要趋势
立即发布
持续释放
延迟发布

第 8 章：市场估计与预测：按胶囊类型，2018 年 - 2032 年

主要趋势
尺寸“000
尺寸“00”
尺寸“0”
尺寸“1”
尺寸“2”
尺寸“3”
尺寸“4”
尺寸“5”

第 9 章：市场估计与预测：按应用划分，2018 年 - 2032 年

主要趋势
抗生素和抗菌药物
维生素和膳食补充剂
抗酸剂和抗气胀製剂
心血管治疗药物
其他治疗应用

第 10 章：市场估计与预测：按最终用户划分，2018 年 - 2032 年

主要趋势
医药行业
保健品业
化妆品产业
研究实验室

第 11 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 12 章：公司简介

ACG
Bright Pharma Caps Inc.
CapsCanada Corporation
Erawat Pharma Limited
HealthCaps India
Lonza Group
Medi-Caps Ltd.
Mitsubishi Chemical Holdings Corporation
Nectar Lifesciences Ltd.
Qingdao Yiqing Biotechnology Co., Ltd.
Seoheung Co., Ltd.

简介目录

Product Code: 8344

Global Empty Capsules Market size will exhibit a 7.7% CAGR between 2024 and 2032, owing to ongoing advancements in capsule manufacturing technologies in line with the increasing preference for both gelatin and non-gelatin capsules. These advancements improve capsule quality, stability, and compatibility with various formulations. Gelatin-based capsules remain popular in the pharmaceutical and nutraceutical sectors, while non-gelatin options like HPMC and pullulan cater to vegetarian and vegan preferences. This dual trend of technological innovation and diverse capsule preferences will propel the empty capsules industry forward.

For instance, in February 2023, Vivion, Inc., a brand of Operio Group and a global ingredient solutions provider, launched a new range of HPMC, empty gelatin, and pullulan capsules.

The empty capsules industry is fragmented based on type, source, functionality, capsule size, application, end-user, and region.

The nutraceuticals industry segment will establish a notable market foothold by 2032, attributed to the increasing demand for dietary supplements and functional foods worldwide. Empty capsules provide a convenient and customizable delivery method for nutraceutical products, appealing to consumers seeking health and wellness solutions. With a focus on natural ingredients and wellness trends, the nutraceuticals industry will drive demand for empty capsules.

The empty capsules market share from the bovine-derived gelatin segment will record a significant uptick from 2024 to 2032 due to its widespread use in pharmaceuticals, nutraceuticals, and dietary supplements. Bovine gelatin capsules offer excellent stability and compatibility with a variety of formulations, making them a preferred choice for manufacturers. With a rising demand for gelatin-based capsules in the pharmaceutical industry and the increasing popularity of nutraceuticals, the bovine-derived gelatin segment will maintain its dominance in the empty capsules market.

Asia Pacific empty capsules market will secure a noteworthy CAGR between 2024 and 2032, driven by expanding pharmaceutical and nutraceutical industries, especially in countries like China and India. Rising healthcare expenditures and a growing aging population also contribute to the demand for empty capsules. With increasing investments in research and development, Asia Pacific will emerge as a key contributor to the market's expansion, offering a wide range of applications in drug delivery and dietary supplements.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancements in empty capsules
  - 3.2.1.2 Growing prevalence of chronic ailments such as cardiovascular diseases worldwide
  - 3.2.1.3 Increasing intake of dietary supplements and vitamins
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Fluctuating raw material prices
  - 3.2.2.2 Cultural practices and dietary restrictions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Million)

5.1 Key trends
5.2 Gelatin based capsules
- 5.2.1 Hard capsules
- 5.2.2 Soft capsules
5.3 Vegetarian capsules

Chapter 6 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Million)

6.1 Key trends
6.2 Porcine gelatin
6.3 Bovine derived gelatin
6.4 Bone meal
6.5 Hydroxy propyl methyl cellulose (HPMC)
6.6 Starch materials & pullulan

Chapter 7 Market Estimates and Forecast, By Functionality, 2018 - 2032 ($ Million)

7.1 Key trends
7.2 Immediate release
7.3 Sustained release
7.4 Delayed release

Chapter 8 Market Estimates and Forecast, By Capsule Type, 2018 - 2032 ($ Million)

8.1 Key trends
8.2 Size "000
8.3 Size "00"
8.4 Size "0"
8.5 Size "1"
8.6 Size "2"
8.7 Size "3"
8.8 Size "4"
8.9 Size "5"

Chapter 9 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

9.1 Key trends
9.2 Antibiotic and antibacterial drugs
9.3 Vitamins and dietary supplements
9.4 Antacid and antiflatulent preparations
9.5 Cardiovascular therapy drugs
9.6 Other therapeutic applications

Chapter 10 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

10.1 Key trends
10.2 Pharmaceuticals industry
10.3 Nutraceuticals industry
10.4 Cosmetics industry
10.5 Research laboratories

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

11.1 Key trends, by region
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa